skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can I get your thoughts on the valuation of the healthcare industry? Could you provide a few picks on dividend paying healthcare stocks?

Thanks,

Joe
Read Answer Asked by Joe on October 20, 2020
Q: Can you please explain what this means & why it is impacting the price? Thanks!
Vaxart (NASDAQ:VXRT) is down 6% premarket on increased volume. Shares have sold off over 20% since last week after it disclosed a $250M at-the-market stock sales deal with Jefferies.
Read Answer Asked by Austin on October 20, 2020
Q: With the recent action taken by the FDA in amending theIr existing emergency use authorisation to include hologic's PANTHER system FOR COVID-19 tests which I understand provides virtually instant results with 100% ACCURACY. !!!!
please rate/Update your opinion of hOLX as a long term investment now ?
John
Read Answer Asked by JOHN on October 20, 2020
Q: I'm looking for some ideas on how to strengthen my healthcare holdings, which only account for 5% of my portfolio. I have a full position in NVO, half positions in CSH.UN and SIS, and have just started to build a position in the PSCH small cap health care fund. GUD and COV are technically present, but both are losers and small enough to ignore/sell.

Q#1: What additions/changes would you suggest for a retired person who is in pretty solid financial shape (5 year holding horizon, can tolerate some risk, but not aiming to shoot out the lights)?

Q#2: What percentage of the total portfolio would you aim to put in healthcare these days? It seems like there are a lot of developments in this field.
Read Answer Asked by Dave on October 20, 2020
Q: I have a full position in WELL but am also intrigued with DOC based on your recent comments. Can you comment on the new appointments in the recent news release and the pedigree of management. Assuming DOC drops closer to the new bought deal price of $2.40 would you be a buyer here?
Thank you
Read Answer Asked by Marty on October 20, 2020
Q: hi group I asked a question on bio tech last Wed - no response as of yet ? - please follow up. The question was do you like the sector/ and what ETFs /top 3 individual stocks do you recommend thanks
Read Answer Asked by Terence on October 19, 2020
Q: Hi there. I hold positions in ABBV, PFE, MRNA, and AMGEN. I am looking for some supplemental help in the healthcare space and considering MDT, WBA, JNJ(on pull back and aware of legal risks).

What would your opinion and/or recommendations be on these companies JNJ/WBA/MDT Do you have one or two alternatives for a dividend conscious investor?

Thank you so much.
Peter
Read Answer Asked by Peter on October 19, 2020
Q: On Oct 1, Beam Therapeutics announced an equity offering priced at $23.50/share; over the following days, the share price declined to as low as $22.24, i.e., below the offering price, though not as low as would reflect the dilutive effect of the new shares.

Yet today shares traded as high as $34.38; what, if anything, can we infer from this disconnect? Who would pay so much when new shares can be had at 2/3 the price?
Read Answer Asked by John on October 16, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!